A detailed history of Cubist Systematic Strategies, LLC transactions in Biote Corp. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 10,560 shares of BTMD stock, worth $32,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,560
Previous 22,900 53.89%
Holding current value
$32,419
Previous $76,000 44.74%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$3.25 - $4.28 $40,105 - $52,815
-12,340 Reduced 53.89%
10,560 $42,000
Q1 2025

May 15, 2025

BUY
$3.23 - $6.2 $73,967 - $141,980
22,900 New
22,900 $76,000

Others Institutions Holding BTMD

About biote Corp.


  • Ticker BTMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 7,574,270
  • Market Cap $23.3M
  • Description
  • biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...
More about BTMD
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.